참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | (S)-4-Benzyl-3-(ethoxyacetyl)oxazolidin-2-one | HCID 10825429 | — |
| 반응물 | 4-Benzyloxy-2-(trifluoromethyl)benzaldehyde | HCID 22273885 | — |
| 반응물 | HCID 178418657 | HCID 178418657 | — |
| 용매 | Triethylamine | HCID 8471 | — |
| 생성물 | HCID 69279901 | HCID 69279901 | — |
반응 단계
In analogy to the procedure described in example 1 a], (S)-4-benzyl-3-ethoxyacetyl-oxazolidin-2-one (for the preparation of (S)-4-benzyl-3-ethoxyacetyl-oxazolidin-2-one see: D. Haigh, H. C. Birrell, B. C. C. Cantello, D. S. Eggleston, R. C. Haltiwanger, R. M. Hindley, A. Ramaswamy, N. C. Stevens, Tetrahedron: Asymmetry 1999, 10, 1353-1367) was reacted with 4-benzyloxy-2-trifluoromethyl-benzaldehyde in the presence of triethylamine and di-n-butylboron triflate to give (S)-4-benzyl-3-[(2S,3R)-3-(4-benzyloxy-2-trifluoromethyl-phenyl)-2-ethoxy-3-hydroxy-propionyl]-oxazolidin-2-one as colorless liquid. According to 1H-NMR spectroscopy, one of the four isomers is strongly predominating. The configuration was tentatively assigned as 2S,3R according to D. Haigh et al., Tetrahedron: Asymmetry 1999, 10, 1353-1367.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06969725B2 |
|---|
| 출처 데이터셋 | uspto-grants-2005_11 |
|---|
| ORD ID | ord-5e14ff88f7014ad287707ab08f759c17 |
|---|
| 출처 메모 | uspto-grants-2005_11 |
|---|